Boston, MA -- (SBWIRE) -- 10/22/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: La Jolla Pharmaceutical Company (OTCBB:LJPC), The Coca-Cola Company (NYSE:KO), MannKind Corporation (NASDAQ:MNKD), Zalicus Inc (NASDAQ:ZLCS).
La Jolla Pharmaceutical Company (OTCBB:LJPC) opened its shares at the price of $0.19for the day. Its closing price was $0.235 after gaining24.34% for the day. The company traded with the total volume of 1.71 million shares, while its average trading volume remained 652,513 shares. The beta of LJPC stands at1.45.
Will LJPC Continue To Move Higher? Find Out Here
La Jolla Pharmaceutical Company, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for chronic organ failure and cancer.
The Coca-Cola Company (NYSE:KO) percentage change surged0.10 % to close at $38.28 with the total traded volume of 12.98 million shares, and average volume of 16.05 million. The 52 week range of the stock remained $35.58 - $43.43, while its day lowest price was $38.60 and it hit its day highest price at $38.95.
Will KO Continue To Move Higher? Find Out Here
The Coca-Cola Company, a beverage company, engages in the manufacture, marketing, and sale of nonalcoholic beverages worldwide. The company primarily offers sparkling beverages and still beverages.
MannKind Corporation (NASDAQ:MNKD) started its trading session with the price of $5.29 and closed at $5.13 by scoring -2.84%. MNKD’s stocks traded with total volume of 3.67 million shares, while the average trading volume remained 5.06 million shares. The beta of MNKD stands at 1.63. Day range of the stock was $5.02 -$5.30.
Will MNKD Get Buyers Even After The Recent Rally? Find Out Here
MannKind Corporation (MannKind) is a development-stage biopharmaceutical company.
Zalicus Inc (NASDAQ:ZLCS) ended its day with the loss of -13.26% and closed at the price of $3.86 after opening at $4.45. Stock traded during its last trading session with the total volume of 1.70 million shares, as compared to its average volume of 994,068 shares.
Will ZLCS Get Buyers Even After The Recent Rally? Find Out Here
Zalicus Inc. (Zalicus) is a biopharmaceutical company that discovers and developsl treatments for patients suffering from pain and immuno-inflammatory diseases.
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)